Tag: generic drug safety
Pharmacist Responsibility for Reporting Generic Drug Problems
Pharmacists play a critical role in spotting and reporting generic drug problems like therapeutic inequivalence and manufacturing issues. Though not legally required in most states, reporting adverse events to the FDA through MedWatch is a professional obligation that protects patient safety.
Post-Market Studies on Generic Drug Safety: What Happens After Approval
Generic drugs are approved based on bioequivalence, not full safety trials. Post-market studies track real-world side effects, manufacturing flaws, and rare reactions that pre-approval studies miss. Here's how the FDA monitors safety after launch.